GlaxoSmithKline’s CEO Andrew Witty and His Work in Developing Nations:…
The recent trend of media and Congress to call drug and pharmaceutical companies the “bad guys,” like Wall Street and AIG, only…
Author
Letters to the Editor: Conflict of Interest in Authorship, and Disclosure…
Last year, Laurence J. Hirsch, a former spokesman for the pharmaceutical manufacturer Merck, wrote an 11-page…
State Policy: New Jersey Senate Committee Passes Conflict of Interest…
Last week, the New Jersey Senate Health, Human Services and Senior Citizens Committee approved a bill—S-369—that will…
State Policy: Minnesota Clarifies Restrictions on Payments to Physicians
In response to recent joint hearings held by the Minnesota Commerce and Labor, and the Business, Industry and Jobs…
FDA Official Cleared of Conflict Allegations in Heparin Contamination Case
Last week Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA was cleared of a conflict of interest…
Continuing Medical Education: Bringing Evidence Based Medicine to Patients
A recent article in the Journal of the American Medical Association (JAMA), titled “Continuing Medical Education: Let the…
Ghost Writing: Crisis or Fact of Life
This past week we have received several journal editorials around the “evils of ghost writing”.
On the writers defense it…
CME Support: Collect Data Before Making Changes
In the recent edition of the American Medical Associations CPPD Report, Todd Dorman, MD, Associate dean and director of the…
Obama Budget for Fiscal Year 2011: Health Care Provisions
This week, the Obama administration released a proposed budget for Fiscal Year 2011, with and overall total spending of $3.834…
Physician Payment Sunshine: Cephalon Reports 2009 Payments to Physician…
As part of their September 2008 corporate integrity agreement, Cephalon posted payments to physician consultants and speakers for…